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Möbius syndrome (MIM no, 157900) consists of a 
congenital paresis or paralysis of the Vllth cranial 
nerve, frequently accompanied by paralysis of other 
cranial nerves, orofacial and limb malformations, 
defects of the musculoskeletal system and mental 
retardation. Although most patients are sporadic 
cases, familial recurrence is not rare. Different 
pedigrees suggest different modes of inheritance. We 
performed linkage analysis in a large family with 
autosomal dominantly inherited Möbius syndrome, 
consisting essentially of asymmetric bilateral facial 
pareses, After exclusion of the candidate region for 
Möbius syndrome on 13q12.2—q13, we localized the 
gene to chromosome 3q21-22, indicating genetic 
heterogeneity of Möbius syndrome. This heterogeneity 
is further proven by the exclusion of both loci in a 
second family with Möbius syndrome.
INTRODUCTION
Mobius syndrome has been defined as a congenital paresis or 
paralysis of the facial nerve that can he accompanied by paralysis 
or dysfunction of other cranial nerves, either unilaterally or 
bilaterally. The nhdueens nerves are most frequently involved 
and, often also, the hypoglossal nerve. Less commonly affected 
are the oculomotor, trochlear, trigeminal, vestibulocochlear or 
glossopharyngeal nerves. Besides the cranial nerve dysfunction, 
orofacial and limb malformations and defects of the
musculoskeletal system are often present in Möbius syndrome. 
Orofacial malformations can consist of bifid uvula, microglossia, 
microstomia, micrognathia, malformations of the jaws, teeth and 
ears, hypertelorism and epicanthus. Limb malformations 
associated with Möbius syndrome are club toot, syndactyly, 
braehydaetyly, eetrodaclyly and absent or deformed fingers and 
toes. Finally, symptoms o f the musculoskeletal system are delects 
of ribs, Klippel-Feil anomaly and aplasia of muscles (1-7).
In one study mental retardation was found in about 10% of the 
patients (8), while in another study it was said to be present in at 
least 50% of the patients (5).
Pathological data on M öbius syndrom e are scarce. M ost cases 
showed aplasia or hypoplasia o f  the affected cranial nerve nuclei 
and/or nerve trunks (9 -13 ). Based on the symptoms and the 
limited pathological observations, rather divergent mechanisms 
have been proposed as the cause o f the syndrome such as 
agenesis, hypoplasia or degeneration o f the nuclei o f the sixth and 
seventh cranial nerves (1,2,13,14).
Möbius syndrome is a rare disorder lor which the incidence in 
the population has not been determined. Most cases are sporadic 
but familial occurrence has been described as well. Different 
pedigrees suggest different modes o f inheritance: autosomal 
dominant, autosomal recessive as well as X-linked recessive 
inheritance have been proposed (15).
Based on the deletion o f  13q 12.2 in a sporadic patient (16) and 
on the co-segregation o f a reciprocal translocation with the 
syndrome in a three-generation family (17) chromosome 
13q 12 .2-q  13 is thought to harbour a locus for Möbius syndrome.
As a first step toward the elucidation o f the genetic defect(s), 
we performed linkage analysis in a large Dutch family with 
autosomal dominantly segregating M öbius syndrome (Fig. 1). A 
branch of the family was described before by Van der Wiel (18). 
We were able, after exclusion o f the candidate region on 
chromosome 13, to localize the M öbius gene in this family to the 
long arm of chromosome 3.
RESULTS
Linkage of Möbius syndrome to chromosome 3q
Linkage analysis was perform ed in the Dutch family described in 
part by Van der Wiel (18). Thirty-one persons were investigated, 
20 of whom were affected and one o f  w hom  was an obligate 
carrier (Fig. 1). The candidate region on chrom osom e 13 
[ 13q 12.2—q 13 (16,17)] was excluded (Table 1). Subsequently, a 
genome scan was started with polym orphic markers spaced 
10-15 cM. After exclusion o f about 15% of the genome, mainly
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Figure 1. Pedigree of the family and haplotypes of persons available for this study. Lines beside the haplotypes mark the mutation carrying chromosome.
of chromosomes 1 and 3, an indication for linkage was obtained 
with marker D 3S196  derived from the long arm o f  chromo­
some 3. The highest lod score with this marker was 2.04 at 
0 = 0.13. A substantial decrease o f the lod score with markers 
located distal to D 3S196  (Table 2) pointed to a more proximal 
location of the disease gene.
Fine mapping of the gene for Mobius syndrome
For fine mapping o f the M obius gene, 12 markers located 
proximal to D 3S196  were tested. Two-point lod scores are given 
in Table 2. The highest lod score was 5.76 at 0 = 0.0 with the 
marker D3S1292.
Haplotypes were constructed to determine the borders of the 
critical region of the Mobius gene (Fig. 1). Recombinations 
visible in the individuals 111.14 and IV.6 demarcated the 
chromosomal fragment co-segregating with the syndrome to a 
region of about 10 cM between the markers D 3SJ589  and
D3S1576. Individual IV.7 is interesting because for the relevant 
interval she carries the same genotype as her unaffected brother. 
On examination, she had minimal signs considered by two 
independent neurologists as compatible with the diagnosis of 
Mobius syndrome. If this clinical diagnosis is correct, it can be 
explained in various ways. The first explanation is that a double 
cross-over has occurred in the paternal chromosome either 
between two adjacent markers or in the intervals in which 
markers in the patient’s father are not informative. The order of 
the markers D3S1290, D3S1273, D3S1587 is not clearly resolved 
(19,20). If the markers D3S1290 and D 3SI273  are assumed to be 
located distal to D3S1292 , there is a coherent interval of about 
4 cM in which the father is non-informative. In this larger interval 
a double recombination is more likely to occur. Additional 
polymorphic markers are necessary to detect this double recom­
bination. Alternative explanations are that individual IV.7 is a 
phenocopy or that gene conversion has occurred.
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Table 1. Two-poinl lod scores between the polymorphic markers derived 
from the candidate locus on chromosome 13 and Möbius svndrome
m
0
Locus 0.00 0.05 0.10 0.20 0.30
DI3S283  (I3ql2.1) -11.26 -3.80 -2.57 -1.31 -0.62
D13S22I ( 13q 12.1) -25.66 -4.04 -2.31 -0.81 -0.23
F I T  I (J3qJ2) -6.64 -2.52 -1.53 -0.61 -0.24
D13S2Î7  ( 13q 12) -23.40 -3.03 -1.62 -0.48 -0.10
DI3S220  ( 13q 12.3-q 13) -12.23 -0,15 0.16 0.24 0.16
DI3S218  ( 13q 13—q 14.1) -4.67 -1.04 -0.71 -0.39 -0.21
Table 2. Two-point lod scores between the polymorphic markers and Mobius 
syndrome
m^ax (0)
Locus 0.00 0.05 0.10 0.20 0,30
D3S1303 -8.26 0.41 0.78 0.88 0.70 0.94 (0.17)
D3S155J -8.06 2.65 2.92 2.53 1.80 2.92 (0.10)
D3SJ589 -10.24 2.21 2.38 2.05 1.38 2.38 (0.10)
D3SI541 2.38 2.12 1.82 1.17 0.57 2.38 (0.01)
RHO 4.61 4.15 3.67 2.64 1.52 4.61 (0.00)
ACPP 3.17 2.89 2.58 1.94 1.23 3.17(0.00)
D3SI273 0.21 5.44 5.13 4.13 2.84 5.46 (0.04)
D3SI290 -1.68 4.51 4.23 3.28 2.08 4.53 (0.04)
D3SI587 2.85 2.59 2.31 1.72 1.07 2.85 (0.00)
D3S1292 5.76 5.27 4.77 3.66 2.44 5.76 (0.00)
D3S1238 L29 1.22 1.13 0.92 0.65 1.29 (0.00)
D3S1576 -1.80 3.71 3.78 3,22 2.27 3.80 (0.08)
D3S196 -9.07 1.53 1.94 1.80 1.26 2.04 (0.13)
D3SJ265 -22.39 -3.90 -2.25 -0.85 -0.29 0.10(0.50)
Location of the markers and marker order are derived from Guapay et cil. (20) 
and Washington et al. (44).
The marker order, given from centromere to telomere, is derived from the recent 
YAC con tig map (19), the genetic map described by Guapay et aL (20) and the 
chromosome 3 data base.
Five-point linkage analysis was performed in order to deter­
mine the location of the gene for Mobius syndrome with the 
highest likelihood (Fig. 2). The analysis resulted in the highest 
probability (lod score 4.59) for a location at D3S1292 with an 
odds ratio of 1.4 between this locus and the next most likely 
location between D3S1587 and D3S1292 (Fig. 2).
DISCUSSION
Linkage analysis in a Dutch family enabled us to localize a gene 
for Mobius syndrome to the long arm of chromosome 3. The 
critical region is delimited by the markers D3S1589 and D3S1576 
and spans about 10 cM at chromosome 3q21-q25.2 (GDB). 
However, from the recent data on physical mapping the more 
precise location of 3q21-q22 can be deduced (19). As soon as 
new markers become available, the critical region might be
reduced. In that case the presence and extent of the co-segregating 
chromosomal fragment in individual IV.7 can be established.
Together with the data indicating a gene for Mobius syndrome 
on chromosome 13 (16,17), the localization of the present gene 
argues for genetic heterogeneity. Genetic heterogeneity has been 
suggested before based on the clinical variability o f  the syndrome 
and the segregation of the disorder in families (7,15 and 
references therein). Linkage analysis performed by us in another 
family, which was described in part by Fortanier and Speyer (21), 
suggests the existence of a third locus involved in Möbius 
syndrome as we excluded both the locus on chromosome 3 and 
the candidate locus on chromosome 13ql2—l 3 in this family.
At the moment about 25 genes have been mapped to an interval 
overlapping with the Mobius critical region. The absence of 
detailed information on the expression pattern o f most of these 
genes makes it difficult to decide whether they are true candidates 
for the Möbius gene. Four of them have or may have a function 
in development: the ZNF9 gene encoding zinc finger protein 9, 
two genes encoding a retinol binding protein, CRB PI and 
CRBP2, and PBX2, a homeobox gene. It has been suggested that 
the ZNF9 protein is involved in regulation of cellular cholesterol 
levels (22) which makes the gene a less likely candidate. The 
same holds true for CRBP2, the expression o f which seems to be 
confined to fetal liver and adult small intestinal mucosa (23). Also 
PBX2 is not very likely to be the Möbius gene. Analysis of 
genomic DNA of the PBX2 copy suggests that this copy is a 
processed pseudogene (24).
CRBPI is located very close to D3S1576 (20,25). Analysis of 
the Taql polymorphism in this gene (26) gave no further clues on 
its location either distal or proximal to D3S1576. In mouse 
development, the gene is widely expressed with a differential 
spatio-temporal pattern (27-29) which includes the migrating 
nucleus of the facial nerve and the mesencepahlic nucleus of the 
fifth cranial nerve (29). This induced us to screen the protein 
coding exons of the CRBPI gene for mutations by single strand 
conformation polymorphism (SSCP) analysis. There were no 
indications for a mutation.
One of the genes for Blepharophimosis-Ptosis-Epicanthus 
inversus Syndrome (BPES), an autosomal dominant disorder of 
craniofacial development (for review see 30), has been localized 
to the same chromosomal region as Möbius syndrome, by both 
linkage analysis (31,32), allelic loss in deletion patients (33) and 
cytogenetic studies (34). Although the syndromes both affect 
craniofacial development they have no symptoms in common and 
a common primary defect seems unlikely. In a patient with a 
balanced translocation one of the breakpoints could be placed 
between D3S1316 and D3SJ615 which is distal to D3S1576 (33), 
and thus outside of the Möbius critical region. However, effects 
of chromosomal aberrations on genes more than 100 kb away 
from the aberration are known (35,36). Therefore, based on their 
location allelism of both conditions cannot be excluded.
MATERIALS AND METHODS
Patients
On examination, the proband (IV.2, Fig. 1) had asymmetric 
weakness of the facial muscles and unequal involvement of the 
muscles of the three branches of the facial nerve. He was reported 
to have been born with facial weakness similar to his maternal 
grandmother and many of her sibs. His mother and his brother

















Figure 2. Five-point linkage analysis resulting in a maximum lod score of 4.59 at D3S1292,
were said to be without facial weakness. On clinical examination 
his brother showed slight asymmetric weakness of the orbicularis 
oculi muscles but his m other had no hint of weak facial muscles. 
Electromyography o f the facial muscles of the mother revealed no 
abnormalities, while in her son, the proband, the right orbicularis 
oris muscle and the right orbicularis oculi muscle revealed 
enlarged polyphasic action potentials. The right blink reflex was 
absent and there was a conduction block of the facial nerve to the 
right orbicularis oculi muscles and a prolonged distal motor 
latency to the orbicularis oculi muscles. The facial muscles on the 
left were not tested. Electromyography was considered compat­
ible with a  neuropathic lesion. Family examination revealed 
asymmetric involvement in all but one case. Individual IV-7 was 
examined by two neurologists independently and was found to be 
minimally affected by both.
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